Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2008

Virulent Shigella flexneri subverts the host innate immune
response through manipulation of antimicrobial peptide gene
expression
Brice Sperandio
Institut Pasteur

Béatrice Regnault
Institut Pasteur

Jianhua Guo
Washington University School of Medicine in St. Louis

Zhi Zhang
Washington University School of Medicine in St. Louis

Samuel L. Stanley Jr.
Washington University School of Medicine in St. Louis

See
next
page
additional
authors
Follow
this
andfor
additional
works
at: https://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Sperandio, Brice; Regnault, Béatrice; Guo, Jianhua; Zhang, Zhi; Stanley, Samuel L. Jr.; Sansonetti, Philippe
J.; and Pédron, Thierry, ,"Virulent Shigella flexneri subverts the host innate immune response through
manipulation of antimicrobial peptide gene expression." Journal of Experimental Medicine. 205,5.
1121-1132. (2008).
https://digitalcommons.wustl.edu/open_access_pubs/546

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Brice Sperandio, Béatrice Regnault, Jianhua Guo, Zhi Zhang, Samuel L. Stanley Jr., Philippe J. Sansonetti,
and Thierry Pédron

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/546

Published April 21, 2008

ARTICLE

Virulent Shigella flexneri subverts
the host innate immune response through
manipulation of antimicrobial peptide
gene expression
Brice Sperandio,1,2 Béatrice Regnault,3 Jianhua Guo,4 Zhi Zhang,4
Samuel L. Stanley Jr.,4 Philippe J. Sansonetti,1,2 and Thierry Pédron1,2
de Pathogénie Microbienne Moléculaire, Département de Biologie Cellulaire et Infection, 2Unité Institut National
de la Santé et de la Recherche Médicale 786, Institut Pasteur, 3Plateforme Puces à ADN, 75724 Paris Cedex 15, France
4Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110

Antimicrobial factors are efficient defense components of the innate immunity, playing a
crucial role in the intestinal homeostasis and protection against pathogens. In this study,
we report that upon infection of polarized human intestinal cells in vitro, virulent Shigella
flexneri suppress transcription of several genes encoding antimicrobial cationic peptides,
particularly the human ␤-defensin hBD-3, which we show to be especially active against
S. flexneri. This is an example of targeted survival strategy. We also identify the MxiE bacterial regulator, which controls a regulon encompassing a set of virulence plasmid-encoded
effectors injected into host cells and regulating innate signaling, as being responsible for
this dedicated regulatory process. In vivo, in a model of human intestinal xenotransplant,
we confirm at the transcriptional and translational level, the presence of a dedicated MxiEdependent system allowing S. flexneri to suppress expression of antimicrobial cationic
peptides and promoting its deeper progression toward intestinal crypts. We demonstrate
that this system is also able to down-regulate additional innate immunity genes, such as
the chemokine CCL20 gene, leading to compromised recruitment of dendritic cells to the
lamina propria of infected tissues. Thus, S. flexneri has developed a dedicated strategy to
weaken the innate immunity to manage its survival and colonization ability in the intestine.

CORRESPONDENCE
Philippe J. Sansonetti:
psanson@pasteur.fr
Abbreviations used: AP-1, activating protein 1; MAPK, mitogen-activated protein kinase;
TLR, Toll-like receptor; TTSS,
type III secretion system.

The efficiency of antimicrobial host defense in
the human intestinal tract relies on the capacity
of the mucosal immune system to recognize
and neutralize pathogens. In this context of
innate immunity, sensing of the bacteria occurs mainly through engagement of host cell
Toll-like receptors (TLRs) and other patternrecognition molecules, such as the nucleotide
oligomerization domain proteins, by pathogenassociated molecular patterns (1–3). After the
pathogen recognition step, the subsequent antimicrobial response is achieved by recruitment
of immune cells and synthesis of antimicrobial
factors by the injured mucosa, including production of molecules such as defensins, cathelicidins, lysozyme, phospholipases, and proteases
that exhibit a broad range of actions against a
variety of pathogens (4, 5).
Dr. Guo died on 18 January 2008.
The online version of this article contains supplemental material.
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Among antimicrobial factors, defensins represent a family of cationic molecules with a
characteristic ␤-sheet–rich fold and a framework
of six disulphide-linked cysteines (4, 6). The two
major human defensin subfamilies, ␣- and ␤defensins, differ in the length of peptide segments
between the six cysteines and the pairing of the
cysteines that are connected by disulphide bonds.
Like defensins, the human cathelicidin LL37
peptide is rich in positively charged amino acid
residues (7). Production by epithelial cells of
the best known ␤-defensins, hBD-1–4 and
cathelicidin LL37, is either constitutive or inducible in response to a proinflammatory situation.
The expression of HBD1 (formally DEFB1)
and HBD4 (DEFB104) genes seems to be essentially constitutive, whereas HBD2 (DEFB4),
HBD3 (DEFB103), and LL37 gene expression
is inducible in response to various signals, such
as bacteria, pathogen-associated molecular
patterns, or proinflammatory cytokines (6, 8).

Supplemental Material can be found at:
http://jem.rupress.org/content/suppl/2008/04/21/jem.20071698.DC1.html
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gonorrhoeae (24, 25). Thus, modulation of the innate defense
system may be a general mechanism facilitating invasion of
pathogenic bacteria at mucosal surfaces.
In this study, by combining in vitro and in vivo approaches,
we clearly demonstrate that S. flexneri actively dampens host
innate immune responses by suppressing transcription of specific antimicrobial peptide genes. We also identify the bacterial effectors controlled by the MxiE transcriptional activator
as the molecules responsible for this mechanism. In vivo, the
strategy used by S. flexneri to modulate transcription of these
target genes was followed by a decrease in the production of
these epithelial cell–encoded peptides, coupled to a deeper
progression of denser population of luminal bacteria toward
crypts. We demonstrate that MxiE-dependent effectors are
also able to down-regulate additional innate immunity genes,
such as chemokine genes, leading to a negative regulation of
the DCs recruitment to the lamina propria of infected human
tissues. The production of antimicrobial molecules and
recruitment of immune cells is one of the major immune
responses dedicated to the protection of the mucosal surfaces, thus, this work highlights the strategy developed by
S. flexneri to subvert the dynamic defense processes of the
intestinal epithelium.
RESULTS
Virulent S. flexneri modulates expression of specific innate
immunity genes in vitro
To investigate whether S. flexneri modulates expression of genes
involved in the intestinal innate immune response, such as
the genes encoding antimicrobial factors, we established
an in vitro model of infection based on polarized and differentiated TC7 or HT29 colonic epithelial cells. This model
mimics the epithelial lining and allows detection of transcripts
for antimicrobial factors whose expression are correlated with
the degree of cellular differentiation (26). Infections were
performed on cell monolayers for 1 h 30 min with the invasive
wild-type S. flexneri strain M90T and its isogenic derivatives:
the invasive mxiE mutant, the noninvasive mxiD mutant, and
the noninvasive plasmid-cured BS176 strain. The mxiE mutant
is impaired for the MxiE transcriptional activator regulating
expression of several virulence factors, such as the Osp and
IpaH proteins, encoded by the virulence plasmid and injected
into cells upon infection, whereas the mxiD mutant is impaired for the assembly of a functional TTSS. The infection
was stopped by addition of gentamicin. Host cell RNAs were
harvested at 1 h 30 min, 3 h, and 4 h 30 min after infection
and analyzed by qRT-PCR for the expression of a selected
set of innate immunity genes.
In noninfected cell monolayers, we observed a basal expression of the ␤-defensins HBD1, HBD2, and HBD3, cathelicidin LL37, chemokine CCL20, and chemokine receptor
CCR6-encoding genes. In contrast, we were unable to detect transcription of the ␤-defensin HBD4 gene in all tested
conditions, including infection experiments (unpublished
data). Infection of TC7 or HT29 cells with the noninvasive
mxiD or BS176 strains was followed by strong transcriptional
SUBVERSION OF THE INNATE IMMUNITY BY SHIGELLA | Sperandio et al.
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Permeabilization of target membranes is the crucial step in
defensin-mediated antimicrobial activity and cytotoxicity (9).
In bacteria, this phenomenon coincides with inhibition of
RNA, DNA, protein synthesis, and a decrease in bacterial
viability (10).
Antimicrobial factors have been linked to the bridging of
innate and acquired immune responses. Indeed, cathelicidin
and various ␤-defensins show chemotactic activity for immune
cells such as monocytes, T cells, or immature DCs, and can
induce cytokine production by monocytes and epithelial cells
(11, 12). Several pieces of evidence indicate that some activities of defensins are receptor mediated, resulting in activation
of downstream signaling events. Indeed, it has been demonstrated that the chemotactic activity of hBD-1, -2, and -3 for
memory T cells and immature DCs is mediated through binding to the chemokine receptor 6 (CCR6), which is the receptor for the chemokine (C-C motif) ligand 20 (CCL20) (12).
Conversely, some molecules with chemotactic properties for
immune cells, such as chemokine CCL20, exhibit antimicrobial
activity against various Gram-positive and -negative bacteria
(13). The rapid expression of antimicrobial factors is thus correlated to the recruitment of adaptative immune cells capable
of directing a long-lasting cellular response to pathogens (11).
Among enteric pathogens, virulent S. flexneri are highly
contagious Gram-negative enteroinvasive bacteria that cause
bacillary dysentery. In malnourished toddlers in the developing
world, untreated infections can be fatal. S. flexneri is unable to
invade intestinal epithelial cells through the apical surface, but
needs to translocate the intestinal epithelium for the development of infection (14). The pathogen translocates through
M cells of the follicle-associated epithelium that covers the
lymphoid nodules associated with the colonic mucosa. In the
subepithelial location, S. flexneri causes apoptosis of resident
macrophages, allowing bacterial escape into the tissues and
efficient basolateral entry into epithelial cells, followed by cell–
cell spread and efficient intracellular growth (15, 16). Subsequent inflammation destroys cohesion of the epithelial barrier,
facilitating further invasion of luminal bacteria and propagation of the infection (17). These complex processes are orchestrated by bacterial effectors that are encoded by plasmid-located
gene clusters and are injected into cells through a type III secretion system (TTSS) (18). Under conditions of secretion,
expression of 12 of these genes is controlled by MxiE, a transcriptional activator of the AraC family (19). MxiE-dependent
proteins are thought to be essential for the infection process,
as exemplified by OspF and OspG, which negatively regulate
the host innate immune response induced by S. flexneri upon
invasion of the epithelium (20, 21).
In the course of the invasion of the human intestinal epithelial lining, S. flexneri is confronted by the surface antimicrobial innate defense systems. Recent studies reported that
S. flexneri may interfere with this host barrier defense system
by down-regulating expression of genes from the innate immune response such as HBD1 and LL37 (22, 23). This immune
escape strategy may also be used by other human pathogens,
such as Salmonella enterica serovar Typhimurium and Neisseria

Published April 21, 2008

ARTICLE

JEM VOL. 205, May 12, 2008

at a MOI of 100, in conditions similar to those used for infection experiments (time course: 1 h 30 min). Values represent the percentage of
cell death. Black bars, TC7 cells; gray bars, HT29 cells. n = 3 independent
biological experiments. Error bars represent the SD.
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Figure 1. Virulent S. flexneri modulates transcription of innate
immunity genes in polarized colonic epithelial cells. (A and B) Expression of ␤-defensins HBD1, HBD2, and HBD3, cathelicidin LL37, chemokine
CCL20, and chemokine receptor CCR6 encoding genes was determined in
TC7 (A) or HT29 (B) cell monolayers 4 h 30 min after infection (3 h after
gentamicin addition). After RNAs extractions and RT reactions, qRT-PCR
was performed on each sample with specific primers to determine the
relative expression of genes in each condition, using the comparative Ct
method. Results are presented on a logarithmic scale as the ratio of gene
expression in infected cells compared with noninfected cells. Black bars,
wild-type strain M90T; gray bars, plasmid-cured BS176 strain; white bars,
mxiD mutant strain; striped bars, mxiE mutant strain. *, P < 0.01 for
infections with the wild-type strain compared with the other strains.
(C) S. flexneri is unable to significantly invade polarized and differentiated
TC7 or HT29 epithelial cells. Gentamicin assays were performed in 6-well
plates (1.5 × 106 cells/well), at a MOI of 100, in conditions similar to those
used for infection experiments (time course: 1 h 30 min). Values represent
the percentage of intracellular CFU. Black bars, TC7 cells; gray bars, HT29
cells. (D) Cellular viability is the same for TC7 or HT29 cell monolayers
infected with the wild-type S. flexneri strain and its derivatives. Lactate
dehydrogenase assays were performed in 6-well plates (1.5 × 106 cells/well),

induction of HBD2, HBD3, LL37, CCL20, and CCR6 genes,
over their basal level that could be observed as early as 1 h
30 min after infection, whereas the HBD1 gene remained
expressed at its basal level of expression throughout the experiments (unpublished data).
In our experimental conditions, the invasive wild-type
strain M90T was unable to significantly invade polarized and
differentiated cell monolayers, as assessed by gentamicin assays (Fig. 1 C), which is in agreement with data obtained in
apically infected polarized Caco-2 cells (14). However, infection experiments with strain M90T showed differential transcriptional expression of the HBD3 and CCR6 genes in both
cell types, and for the LL37 gene in TC7 cells only, compared with infections with the noninvasive mxiD and BS176
strains (Fig. 1, A and B). At 4 h 30 min after infection, transcription of these genes in infected cells was induced to a
lesser extent by the wild-type strain M90T compared with
the mxiD and BS176 strains. In TC7 cells, the HBD3 gene
expression was induced only 4-fold by M90T compared with
>110-fold by BS176 (Fig. 1 A). Conversely, expression of
HBD1, HBD2, and CCL20 genes was found to be similar for
all infections with the two cell lines (Fig. 1, A and B). As a
control, cellular viability was the same for monolayers infected
with the wild-type S. flexneri strain and its derivatives, as assessed by lactate dehydrogenase assays (Fig. 1 D). Collectively,
these results indicate that wild-type S. flexneri impairs expression
of specific innate immunity genes by injecting virulence factors into epithelial cells through its TTSS, thereby affecting
the host immune response.
The S. flexneri MxiE regulon includes >10 virulence proteins delivered through the TTSS upon contact of the bacteria
with cells. Among them, the OspF and OspG effectors have
been shown to target the host NF-B and mitogen-activated
protein kinase (MAPK) signaling pathways (20, 21, 27, 28).
Expression of the genes encoding these proteins is dramatically affected in a mxiE mutant, therefore preventing their
synthesis and injection into cells upon infection (19). However, the mxiE mutant still has a functional TTSS for injection of the MxiE-independent effectors, allowing an efficient
invasion of nonpolarized epithelial cells, comparable to the
M90T wild-type strain (19, 47). To determine whether the
pool of MxiE-dependent effectors was involved in the host
innate immunity gene’s down-regulation, we carried out infection experiments with the invasive mxiE mutant. Like observed for the wild-type strain M90T, the mxiE mutant was
unable to significantly invade polarized and differentiated TC7
or HT29 cells (Fig. 1 C). However, in contrast to M90T, the
mxiE mutant was unable to modulate transcription of HBD3,
LL37, and CCR6 genes in infected cell monolayers (Fig. 1,
A and B). Transcription of these genes, as well as of the other
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weak down-regulation was observed for CCR6 gene expression
(Fig. 2). Interestingly, the wild-type S. flexneri strain M90T
conserved its capacity to actively repress HBD3 gene expression in IL-1␤–stimulated cells (Fig. 2). As expected, the
mxiE mutant strain, as well as the mxiD and BS176 strains,
were still unable to modulate HBD3 gene induction in IL-1␤–
treated cells (Fig. 2). Similarly, wild-type bacteria repressed
CCR6 gene transcription in stimulated cells, whereas mxiD
and mxiE mutants failed to dampen its expression in similar
conditions (Fig. 2). Collectively, these in vitro results indicate
that virulent S. flexneri manipulates the host innate immune
response through injection of the MxiE-dependent effectors,

Figure 2. S. flexneri modulates transcription of innate immunity
genes in cells expressing an inflammatory response pattern. Expression of the ␤-defensins HBD1, HBD2, and HBD3, cathelicidin LL37,
chemokine CCL20, and chemokine receptor CCR6 encoding genes was
determined at 4 h 30 min after infection (3 h after gentamicin addition)
in TC7 cells that were prestimulated for 2 h by IL-1␤. After RNA extractions and reverse transcription reactions, qRT-PCR was performed on each
sample with specific primers to determine the relative expression of genes
in each condition, using the comparative Ct method. Results are presented
on a logarithmic scale as the ratio of gene expression in stimulated and
infected cells compared with nonstimulated and noninfected cells. Light
gray bars, noninfected; black bars, wild-type strain M90T; gray bars, plasmidcured BS176 strain; white bars, mxiD mutant strain; striped bars, mxiE
mutant strain. n = 3 independent biological experiments. Error bars represent the SD. *, P < 0.01 for infections with the wild-type strain compared
with the other strains.

Figure 3. Antimicrobial factors whose transcription is repressed by
S. flexneri are those affecting highest bactericidal activity against
the pathogen. (A) Bactericidal activities of synthetic ␤-defensins hBD-1,
hBD-2, and hBD-3, cathelicidin LL37, or recombinant chemokine CCL20
were determined on S. flexneri exponential cultures growing in DME
medium for 2 h at 37°C. hBD-1, hBD-2, hBD-3, and LL37 were used at
50 μg/ml, whereas CCL20 was used at 5 μg/ml final concentration. Values
expressed in arbitrary fluorescent units (afu) represent the mean fluorescence of the bacterial population analyzed. Black bars, wild-type strain
M90T; gray bars, plasmid-cured BS176 strain; white bars, mxiD mutant
strain; striped bars, mxiE mutant strain. *, P < 0.01 for the fluorescence
obtained with the BS176 strain compared with the other strains. (B) L. monocytogenes and L. innocua were used as positive controls for antimicrobial
activity of these factors inefficient on S. flexneri in our experimental conditions. Black bars, L. monocytogenes; gray bars, L. innocua. n = 3 independent experiments. Error bars represent the SD.
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genes studied, was similar in cells upon mxiE, mxiD, or BS176
infection (Fig. 1, A and B). In addition, infection experiments performed with mutant strains defective for the ospF
or ospG genes revealed that the encoded effectors repressed
antimicrobial factor genes transcription (unpublished data).
However, the extent of repression was inferior to the one
observed with the whole set of effector proteins delivered by
the M90T strain, suggesting additive synergistic action of these
effectors to get full repression of the antimicrobial peptide genes
expression. Thus, the pool of MxiE-dependent effectors injected in cells upon infection is responsible for the observed
manipulation of the host immune response through transcriptional dampening.
Expression of several genes of the innate immune response is known to be up-regulated in intestinal epithelial cells,
by treatment with proinflammatory molecules such as IL-1␤,
TNF-␣, or IFN-␥ (4). To determine whether S. flexneri was
still able to modulate transcription of innate immunity genes
in cells induced to undergo an inflammatory response pattern,
TC7 cell monolayers were stimulated by IL-1␤ for 2 h, the
IL-1␤–containing medium was removed, and S. flexneri infections were performed. IL-1␤ treatment was followed by an
induction of the HBD2, HBD3, and CCL20 genes transcription in noninfected cells (Fig. 2). In the same conditions, expression of the HBD1 gene remained unchanged, whereas a

SUBVERSION OF THE INNATE IMMUNITY BY SHIGELLA | Sperandio et al.
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even in cells already expressing an inflammatory pattern, a
situation that is likely to prevail in the dynamics of interactions between luminal bacteria and the epithelial lining in
the course of an infection.

Figure 4. S. flexneri manipulates expression of genes from the innate immune response in human intestinal xenografts. (A) Human tissues
were infected for 2 h by direct intraluminal inoculation with 5 × 107 bacteria. Total RNA was extract from a section of each infected grafts, cRNA were
synthesized and hybridized on the Affymetrix U133A GeneChip Human Array. Gene expression profiles from two experiments corresponding to the noninfected condition (NI), BS176 infection (BS176), M90T infection (M90T), and mxiE infection (mxiE), are shown. Hierarchical clustering of immunity genes
was performed using dChip software with Euclidian distance and average as a linkage method. Before clustering, expression values for one gene across all
samples were standardized to produce a mean of zero. Increased or decreased values were then ranged compared with that mean. Red and blue colors
represent expression that is higher or lower than the mean value, respectively. The key for intensity of expression is indicated under the bar. (B) Validation/
determination by qRT-PCR of ␤-defensins HBD1, HBD2, and HBD3, cathelicidin LL37, chemokine CCL20, and chemokine receptor CCR6 genes expression
in infected tissues used for GeneChip experiments. After reverse transcription reactions, qRT-PCR was performed on each sample with specific primers to
determine the relative expression of genes in each condition using the comparative Ct method. Results are presented on a logarithmic scale as the ratio
of gene expression in infected tissues compared with noninfected tissues. Black bars, wild-type strain M90T; gray bars, plasmid-cured BS176 strain;
striped bars, mxiE mutant strain. n = 2 independent biological replicates per condition.
JEM VOL. 205, May 12, 2008
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Antimicrobial factors whose transcription is repressed
by S. flexneri are those affecting the highest bactericidal
activity against the pathogen
To measure the antimicrobial activity of innate immune factors such as ␤-defensins hBD-1, hBD-2, and hBD-3, cathelicidin LL37, and chemokine CCL20 on S. flexneri viability, we
determined the in vitro antimicrobial activity of each of these
peptides against the pathogen, using synthetic or recombinant molecules. Typically, the conditions used for demonstrating activity of antimicrobial peptides include buffers of
low ionic strength and neutral pH that allow for optimal killing because the activity of most antimicrobial factors is antagonized by high salt concentrations, the presence of divalent
cations, and serum components (4). For this purpose, the

wild-type strain M90T and its derivatives mxiD, mxiE, and
BS176, were sampled in the exponential phase, resuspended,
and cultured for 2 h in 1:2 diluted DME culture medium
(salts 0.08 M, pH 7.2; no serum) containing the relevant antimicrobial peptide. The DiBAC fluorescent reagent that is
able to cross-depolarize bacterial membranes was added to
cultures, followed by FACS analysis of bacterial fluorescence
(mean fluorescence) (29).
In these conditions, ␤-defensins hBD-1 and -2 were
inactive on the S. flexneri wild-type strain and its derivatives, as
assessed by the weak fluorescence values obtained (Fig. 3 A).
Conversely, the ␤-defensin hBD-3 exhibited strong bactericidal
activity on the pathogen at a similar concentration (Fig. 3 A).
Interestingly, the plasmid-cured BS176 strain was twofold more
sensitive to hBD-3 than the other strains, as confirmed by
CFU assays (unpublished data), suggesting that proteins encoded by the virulence plasmid achieve higher bacterial resistance to this antimicrobial factor. To explore the possibility
of plasmid-encoded proteolytic degradation of hBD-3, we
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S. flexneri regulates expression of innate immunity genes
in vivo
To confirm in vivo that virulent S. flexneri down-regulates
expression of antimicrobial factors, we performed a transcriptomic analysis of xenotransplanted human intestinal segments
after infection for 2 h by the wild-type strain M90T, the
mxiE mutant, and the avirulent strain BS176. Xenografts injected with bacterial medium alone were used as a reference.
Xenotransplants exhibit a chimerical structure, combining essentially human intestinal epithelium and mouse vascular and
immune cells. Infection of these tissues for short time periods
allowed for the study of gene transcription in human epithelial cell, thanks to the use of human-specific arrays. Two independent array hybridization experiments were performed
for each condition, and the hierarchical clustering of modulated gene expression was determined. Among them, we spe-

cifically focused our attention on genes encoding chemokines,
cytokines, and antimicrobial peptides (Fig. 4 A). Validation
of data were performed on a set of genes, including HBD2
and HBD3, whose probe sets were absent from the used arrays,
using qRT-PCR (Fig. 4 B). From this gene cluster, we identified a total of 46 genes whose expression was significantly
modulated by S. flexneri in infected intestinal xenotransplants.
Interestingly, 11 genes were less transcribed upon infection with the wild-type strain M90T compared with the
invasive mxiE mutant or the noninvasive BS176 strain (Fig.
4, A and B). These targets of the MxiE-dependent effectors
included genes encoding chemokines and chemokine receptors, such as CCL3, CCL4, CCL20, CCL25, and CCRL2.
Mainly produced by epithelial cells, these proteins are involved
in the recruitment and activation of inflammatory and immune effectors cells such as monocytes, DCs, and T cells (31).
Expression of genes encoding cytokines IL-7 and -18 and
cytokine receptors IL-13RA1 and -20RA was also less expressed in human tissues infected by the M90T strain compared with the mxiE mutant. IL-7 is produced locally by
intestinal epithelial and goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes, whereas
IL-18 induces IFN-␥ production by T cells. Finally, among
down-regulated genes, as measured by qRT-PCR, expression
of ␤-defensins HBD1 and HBD3 was strongly reduced in
xenotransplants infected by wild-type bacteria compared with
mxiE mutants; ratios were 0.09:1.09 for HBD1 and 0.1:0.82
for HBD3, respectively (Fig. 4, A and B).
In addition to down-regulating the expression of several
genes encoding chemokines, cytokines, and antimicrobial peptides, transcriptional analysis indicated that MxiE-dependent
bacterial effectors up-regulate the expression of the SOCS2
gene (Fig. 4 A). Interestingly, members of this family are
cytokine-inducible negative regulators of cytokine signaling
pathways whose primary function is to attenuate JAK–STAT

Figure 5. S. flexneri blocks hBD-1, hBD-3, and CCL20 expression in human intestinal xenografts. Anti–human hBD-1 (A and B), anti–human
hBD-3 (C and D), and anti–human CCL20 (E and F) immunostainings of human intestinal xenograft sections after 2 h of infection with the wild-type
S. flexneri strain M90T (A, C, and E) or the mxiE mutant (B, D, and F). Arrows indicate the poor luminal release of hBD-1 (A), hBD-3 (C), and CCL20 (E) by
epithelial cells, typically observed in tissues infected by wild-type bacteria. Arrowheads highlight areas of extensive release of hBD-1 (B), hBD-3 (D), and
CCL20 (F) by epithelial cells, typically found in mxiE-infected tissues. n = 4 independent biological replicates per condition. Bars, 10 μm.
1126
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tested the activity of the defensin in the presence of S. flexneri
mutants defective for the expression of the surface/secreted
proteases SepA or SopA that are encoded by the virulence
plasmid, and the sepA-BS176–complemented strain (18, 30).
No change in bacterial sensitivity was observed with any of the
mutant strains, suggesting that S. flexneri is unlikely to proteolytically degrade the antimicrobial factors (unpublished data).
Finally, among the antimicrobial factors tested, cathelicidin
LL37 and chemokine CCL20 exhibited an intermediary antibacterial action on S. flexneri compared with hBD-1-2 and
hBD-3 (Fig. 3 A). As a control of our experimental conditions, Listeria monocytogenes and Listeria innocua were tested
and found to be sensitive to all the antimicrobial peptides
tested, except for cathelicidin LL37, at equivalent concentrations (Fig. 3 B). Collectively, these results show that among
the molecules tested in vitro, the most active antimicrobial
factors for S. flexneri are those whose expression is repressed
by the virulent bacterium at the transcriptional level.
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signaling. In turn, a potential role of the JAK–STAT signaling pathway in down-regulating expression of HBD1 and
HBD3 has been suggested (32). Collectively, these in vivo
results show that S. flexneri is able to manipulate the host innate immune response through its MxiE-dependent effectors
by up- or down-regulating expression of crucial innate immunity genes.

Blocking of antimicrobial factor expression correlates with
deeper progression of S. flexneri toward intestinal crypts
Such epithelial cell manipulation for antimicrobial factor expression may represent a critical mechanism allowing S. flexneri
to more deeply colonize and invade the mucosa. At 2 h after
infection, the presence of the M90T wild-type strain and the
mxiE mutant in the lamina propria of infected xenotransJEM VOL. 205, May 12, 2008

Figure 6. Blocking of antimicrobial peptides expression correlates
with deeper progression of S. flexneri toward intestinal crypts. Anti–
S. flexneri 5a LPS immunostainings of human intestinal xenograft sections
after 2 h of infection with the wild-type S. flexneri strain M90T (A), the
mxiE (B), or the mxiD (C) mutant strains. Arrow indicates the M90T bacteria diffusely distributed in the mucus layer from the top of the villi to the
crypts (A). Arrowheads highlight the mxiE and mxiD mutants localized
close to the top of the villi or engulfed into the luminal mucus (B and C).
(D) Bacterial counts in the mucosal tissue. The anti–S. flexneri 5a LPS immunostaining sections were used to count the bacteria localized at the
top of the villi (upper third), in the luminal intervilli spaces (intermediate
third), and in the crypts (lower third). A representative set of 10 villi per
section was analyzed, and three sections were read for four independent
biological replicates per condition. Results are presented as a percentage
of the amount of bacteria found at each location. The 100% is defined by
the amount of M90T bacteria determined at the upper third of the villi.
Black bars, wild-type strain M90T; striped bars, mxiE mutant strain; white
bars, mxiD mutant strain. n = 4 independent biological replicates per condition. Bars, 10 μm.
1127
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S. flexneri blocks antimicrobial factors expression in vivo
Our study so far has shown that MxiE-dependent S. flexneri
effectors modulate expression of a subset of genes encoding
molecules involved in the host innate immune response. Therefore, we investigated the in vivo consequences of this strategy
in intestinal tissues infected by the pathogen. For this purpose, xenotransplants were infected for 2 h with the wild-type
strain M90T, the mxiE mutant, the noninvasive mxiD mutant
harboring an inactive TTSS, or injected with bacterial culture medium alone as control. Immunolabelings were performed on infected tissues with antisera to human ␤-defensins
hBD-1, hBD-3, and chemokine CCL20. Noninfected tissues revealed weak staining for hBD-1 and no labeling for
hBD-3 and CCL20, which is in agreement with the respective
constitutive and inducible production of these molecules by
epithelial cells in vivo (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20071698/DC1). Interestingly,
in tissues infected by the wild-type strain M90T, hBD-1 and -3
staining exhibited a weak labeling after the villi contours, suggesting poor synthesis and release of these molecules in the lumen (Fig. 5, A and C). Conversely, in mxiE mutant-infected
tissues, massive luminal release of these antimicrobial peptides
was observed from epithelial cells exposed to the colonizing
bacteria, imprinting the portion of the mucus layer proximal to
the epithelial surface (Fig. 5, B and D). As expected for their
profile, ␤-defensin hBD-2 immunostainings were similar
in human xenografts infected by wild-type and mxiE mutant
bacteria (unpublished data). In agreement with the transcriptional data from xenografts, CCL20 labeling showed strong
production of this chemokine by enterocytes along villi with
luminal efflux in the transplants infected by the mxiE strain,
whereas only a weak signal was detected in tissues infected by
the M90T strain (Fig. 5, E and F). Other defensin- and chemokine-staining experiments indicated a similar staining pattern
for mxiD- compared with mxiE-infected xenografts (Fig. S1, B,
D, and F). Collectively, these experiments indicate that MxiEdependent S. flexneri effectors affect the production of hBD-1,
hBD-3, and CCL20 molecules exhibiting antimicrobial activities, thereby weakening the antimicrobial defense barrier at
infected mucosal surfaces.

plants was observed only in few occasions (unpublished data).
However, the strong epithelial expression of antimicrobial
factors observed at the same time indicates the establishment
of a mucosal inflammatory response (Fig. 5 and Fig. S1). This
situation prompted us to study how the epithelial inflammatory response affected the behavior of bacteria at the mucosal
surface, especially their ability to progress toward crypts through
intervilli spaces. For this purpose, we performed a qualitative
and quantitative analysis of the bacterial distribution from the
top of the villi to the crypts of xenotransplants infected for 2 h
with the wild-type strain M90T or with the mxiE and mxiD
mutants. Qualitatively, S. flexneri 5a LPS immunostainings
revealed that wild-type bacteria were distributed more diffusely in the mucus layer than mxiE and mxiD mutants, whose
localization remained close to the top of the villi, essentially
trapped in the luminal mucus (Fig. 6, A–C). In addition,
mxiE and mxiD mutants were barely seen localized in luminal
intervilli spaces or deep near the crypts, compared with wildtype bacteria that affected a much deeper diffusion pattern
(Fig. 6, A-C). Quantitatively, the amount of M90T bacteria
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as a poor migration into the lamina propria with much less
staining than observed in noninfected tissues for resident DCs
(Fig. 7, A and C). Collectively, these experiments highlight
the existence of a dedicated MxiE-dependent system allowing S. flexneri to suppress expression of immune effectors,
leading to compromised recruitment of DCs to the lamina
propria of infected tissues.

S. flexneri compromises recruitment of DCs to the lamina
propria of infected tissues
The ␤-defensins hBD-1 and -3, and the chemokine CCL20,
are immune effectors known to have both antimicrobial
properties and chemotactic activities. Our study so far has
shown that the blocking of their expression at the mucosal
surface by S. flexneri was coupled to deeper progression of
bacteria toward crypts. To correlate these findings to mouse
immune cell trafficking, additional immunostaining experiments were performed using a monoclonal antibody to mouse
CD11c, one of the main antigens present on the surface of
DCs. CD11c staining of mxiE-infected tissues revealed massive recruitment of DCs into the lamina propria and submucosal regions; they are probably attracted by the gradient of
chemotactic molecules, such as CCL20, emanating from epithelial cells (Fig. 7 B). Similar observations were obtained in
mxiD-infected tissues (Fig. 7 D). In contrast, M90T-infected
xenotransplants showed a very different pattern characterized
by a restricted presence of DCs in submucosal areas, as well

DISCUSSION
The human intestinal epithelium achieves a barrier function
between the host’s “milieu intérieur” and the outside environment, particularly the gut microbiota. This barrier protects
against invasion and systemic dissemination of both commensal
and pathogenic microorganisms. The epithelium can be seen
as comprising three barriers in one: a physical barrier, an innate immune barrier, and an adaptive immune barrier (33).
Accessibility to the apical surface of epithelial cells and rupture of the physical barrier are among the main properties
that distinguish pathogens from commensals. Among the numerous factors that participate in establishment and maintenance of epithelial homeostasis, antimicrobial factors that are
ubiquitously expressed by epithelial cells throughout the gastrointestinal tract play an important regulatory role in controlling the resident and transient bacterial populations (34).
Moreover, epithelial cells and DCs act as sentinels at mucosal
surfaces and secrete chemokines that recruit, activate, and regulate inflammatory infiltrates, including polymorphonuclear
leukocytes transmigrating through the epithelium, resident
macrophages, recruited monocytes, and a variety of lymphocytes. These effectors participate in the innate response to
commensals under steady-state conditions, a situation of tolerance that commensals themselves actively maintain (35). In
addition to maintaining efficient physical and innate immune
barrier functions, the intestinal epithelium also takes an active
part in the induction of adaptive immune surveillance at the
mucosal surface. After sampling luminal bacteria, DCs migrate to mesenteric lymph nodes and initiate an adaptive immune response directing specific IgA production in the lamina
propria (36). Mucosal defense mechanisms also encompass
cellular factors, including B and T cells, and lymphocytes unique
to the gut-associated lymphoid tissues, such as lamina propria
lymphocytes (37).
However, homeostasis of the epithelial barrier can be
subverted by crosstalks between enteric bacterial pathogens
and mucosal tissues. The genetic make up of bacterial enteric
pathogens can therefore be seen in the perspective of a coevolutionary process that has led to the presence of genes and
pathogenicity island encoding effectors able to disrupt this
homeostatic process and to resist to its essentially inflammatory
consequences. Because antimicrobial peptides appear to be
primary effectors throughout evolution to fight microbes and
represent in the vast majority of species, particularly in insects, the first line of defense in the absence of an adaptive
immune response (38), it would not be surprising if the genome
of pathogens such as S. flexneri had evolved to respond to this
vital constraint. How this is achieved is just being unraveled.

Figure 7. S. flexneri compromises the DCs recruitment in human
intestinal xenografts. Anti–mouse CD11c immunostainings of human
intestinal xenograft sections after 2 h of infection with the wild-type
S. flexneri strain M90T (A), the mxiE mutant (B), the mxiD mutant (D), or in
noninfected tissues (C). Arrow indicates the poor DC recruitment in submucosal areas, as well as in the lamina propria, typically observed in tissues infected by wild-type bacteria (A). Arrowheads highlight the resident
DC in noninfected tissues (C), or the massive recruitment of DCs into the
lamina propria and their accumulation in submucosal regions, typically
found in tissues infected by the mxiE (B) or mxiD (D) mutants. n = 4 independent biological replicates per condition. Bars, 10 μm.
1128

SUBVERSION OF THE INNATE IMMUNITY BY SHIGELLA | Sperandio et al.

Downloaded from jem.rupress.org on September 13, 2011

observed in the lower third of the villi, including the crypt
areas, was close to the half of the one determined at the upper
third (Fig. 6 D). Collectively, these results highlight the correlation existing between the ability of virulent S. flexneri to
block antimicrobial factors expression, and their capacity to
progress deeply and massively toward intestinal crypts, at the
early time point of infection.
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response elements. Moreover, the inhibition of HBD3 gene
transcription observed with both the NF-B inhibitor PDTC
and the p38 inhibitor suggests the possibility of the existence
of NF-B binding motifs (42). As suggested earlier, one could
even hypothesize that the selective pressure for acquisition of
the diversity of Osp and possibly IpaH effectors, the latter being
a new class of E3 ubiquitin ligases with no known substrate as
yet (43), has been partly driven by the need to transcriptionally
suppress expression of defense genes whose activation and
regulation is complex and multifactorial.
Antimicrobial peptides exhibit a strong antibacterial activity toward Gram-negative and -positive bacteria, as observed
for hBD-3 on S. flexneri and Listeria, as well as an ability to act
as chemoattractants for immune cells (4). With such properties,
it seems logical that pathogens have developed mechanisms
to resist these immune effectors. The main strategies for pathogenic bacteria to thwart cationic peptides are to die and act as
decoys, to degrade them, to block their action, or to suppress
their expression, particularly at the transcriptional level (44).
The latter option appears to be the strategy that S. flexneri has
evolved, along with other pathogens such as Salmonella and
Neisseria, although the mechanisms used by these two pathogens
to interfere with the host signaling pathways are so far uncharacterized (24, 25). Finding the S. flexneri effectors and
the molecular mechanisms that dampen the transcription of
antimicrobial peptides will lead to a better understanding
of the complex circuits that induce and regulate their expression, and will provide another example of the contribution
of bacterial virulence factors to decipher basic physiological
mechanisms (45).
Exposure of the intestine to microbes maintains steadystate “physiological inflammation” at mucosal surfaces, a situation preventing tissue invasion by commensal microorganisms.
In this scheme, DCs orchestrate the innate and the adaptive
immune responses, playing a central role in properly interpreting signals that maintain tolerance versus those that should
trigger a neutralizing adaptive immune response against pathogens. As such, pathogenic bacteria have multiple opportunities to subvert the immune response at the level of DCs.
In this study, S. flexneri was found to down-regulate innate immunity genes such as CCL20, the main DC chemoattractant,
leading to compromised recruitment of DCs to the lamina
propria of infected tissues. By blocking the recruitment of DCs
to the site of infection, S. flexneri potentially interferes with
the tolerogenic process, and thus uncontrolled inflammation
that is known to facilitate disruption of the epithelial barrier
and facilitate further mucosal invasion (17). An inhibition of
DC recruitment may also strongly interfere with the critical
step of transition between the innate and adaptive response,
which will decide upon the switch toward a Th1, Th2, or
Th17 response, the development of this response, and the
triggering of immunological memories. These issues are essential to bear in mind for the development of a rationally attenuated live oral vaccine candidate against S. flexneri. The
difficulty of the equation now appears to maintain a strong
protection against killing by epithelial defenses to achieve
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Epithelial cells mediate and orchestrate this dialog mainly
through activation of proinflammatory pathways, particularly
the NF-B– and activating protein 1- (AP-1) signaling pathways (39). To gain access to the epithelial surface, to colonize
it, and to then possibly disrupt this barrier and invade the
mucosa, pathogens have evolved strategies to overcome the
development of antimicrobial immune responses. Pathogenic
bacteria, such as S. flexneri, Salmonella, or Yersinia, have elaborate strategies targeting specific steps of the NF-B and MAPK
pathways that allow them to interfere with the transcription
of immune response genes from epithelial cells (20, 39).
Rectal biopsies from patients with bacillary dysentery revealed that expression of the antibacterial peptides HBD1 and
LL37 was reduced (22, 23). This was the first indication that
S. flexneri might abrogate expression of some key antimicrobial peptides as part of a possibly more global strategy of manipulating the mucosal innate immune response. Thus, this
observation needed to be confirmed and analyzed in light of
accumulating data on S. flexneri pathogenesis, particularly the
evidence that the TTSS of S. flexneri allows injection of protein effectors that have the capacity to target specific steps of
activation of key innate response pathways, such as the NF-B
pathway into epithelial cells. OspG, which is one of the plasmidencoded MxiE-regulated proteins, is a kinase that binds a
limited set of ubiquitinated E2 enzymes, particularly those involved in the degradation of I-B, thereby blocking their
function and preventing translocation of the NF-B complex
into the nucleus (21). On the other hand, the OspF effector,
which is a phosphothreonine lyase that reaches the host cell
nucleus, dephosphorylates the MAPK Erk1/2 and p38, thereby
leading to the dephosphorylation of histone H3. Subsequent
epigenetic modifications impair the accessibility of the NF-B
complex on a series of promoters (20, 28). The ospF and ospG
genes are essentially under the control of MxiE, the master
regulator of the regulon encoding >10 plasmid-borne genes
(19). Their transcription is triggered by activation of the TTSS;
thus, as soon as bacteria establish contact with target cells, these
proteins are expressed and secreted into cells that, at the same
time, undergo strong proinflammatory signaling via the TLR
and nucleotide oligomerization domain pathways. This system
offers the opportunity to bacteria to suppress the expression of
genes whose promoters contain NF-B and AP-1 motifs, as
well as possibly other regulatory sequences.
Antimicrobial peptide-encoding genes have mosaic promoters characterized by the presence of NF-B, AP-1, and
others regulatory boxes. Given our current understanding of
signaling pathways targeted by the MxiE-regulated effectors,
these genes are therefore excellent candidates to be regulated
by the set of effectors under the mxiE regulon. This is the case
for the ␤-defensin HBD2 whose expression has been shown
to be mediated through NF-B, sometimes assisted by AP-1,
MAPK, and protein kinase C (40, 41). A potential role of
the JAK2–STAT signaling pathway has been suggested in the
control of HBD1 and HBD3 expression (32). Indeed, the
HBD3 gene promoter contains transcriptional binding motifs
for AP-1, IFN-␥ interferon response elements, and NF-IL-6
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proper colonization, to control the intensity of the inflammatory response to achieve optimal tolerance while disconnecting
the mechanisms of immunosuppression to achieve maximum
immunogenicity and memory.
MATERIALS AND METHODS

Polarized and differentiated cell monolayer infections. TC7 (49) and
HT29 human epithelial cells derived from colonic carcinoma were cultured
in 6-well plates (1.5 × 106 cells/well) with DME (Invitrogen) supplemented
with 10% FCS (Invitrogen), 1% nonessential amino acids (Invitrogen),
100 U/ml penicillin, and 100 μg/ml streptomycin (Invitrogen) in 10% CO2.
To obtain polarized and differentiated cell monolayers, cells were grown for
3 wk to reach full differentiation and polarization. Culture medium was
changed three times per week. Infections were performed in triplicate in
DME without serum at a multiplicity of infection (MOI) of 100. When
specified, cells were stimulated for 2 h with 20 ng/ml IL-1␤ (R&D Systems), after which IL-1␤–containing medium was removed and infections
were performed. To facilitate S. flexneri infection, the cell culture plates were
spun gently for 10 min at 1,000 rpm at room temperature, and then stored
at 37°C. After 1 h 30 min of infection, 50 μg/ml gentamicin (Invitrogen)
was added, cells were incubated for the appropriate length of time, washed
with PBS, and lysed for RNA isolations. Gentamicin assays (14) and lactate
dehydrogenase assays (CytoTox; Promega) were performed on TC7 or
HT29 cell monolayers under similar conditions of infection.
Human intestinal xenograft infections. Human intestinal xenografts
were placed into the subscapular region of 6–8-wk-old SCID mice, as previously described (50). Grafts were allowed to develop for 10 wk before use,
and then human tissues on mice were infected by direct intraluminal inoculation with 5 × 107 S. flexneri bacteria. A group was mock infected by inoculation with media alone, as a control. At 2 h after infection, animals were
killed, and grafts were removed and frozen for Trizol RNA isolation (Invitrogen), or for immunohistological analysis. In the latter case, they were embedded on OCT compound (Sakura) and frozen in isopentane-dry ice. For
RNA isolations, a subsequent cleanup was performed using the RNeasy
Mini kit (QIAGEN). For the transcriptomic and the histological approaches,
two and four biological replicates were performed, respectively. Animal experiments were done according to the guidelines of the Institut Pasteur’s
ethical committee for animal use in research.
GeneChip hybridization and statistical analysis. After infections, a section of each graft was removed and homogenized with an Ultra-Turrax apparatus (Janke and Kunkel, GmbH and Co.) in 2 ml of Trizol (Invitrogen).
Total RNA was extracted according to the manufacturer’s instructions and
cleaned by a subsequent purification using the RNeasy Mini kit (QIAGEN).
RNA quantity and quality were analyzed by the Agilent Bioanalyzer (Agilent). The cRNA synthesis, hybridization, and labeling were carried out as
previously described (51). 10 μg of cRNA were fragmented and hybridized
to the U133A GeneChip Human Array (Affymetrix). After PE-Streptavidin
staining, arrays were scanned at 488 nm using an argon-iron laser. Data were
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RNAs isolation and quantitative real-time PCR. RNAs were isolated
using the RNeasy Mini kit. RT-PCR reactions were performed on 4-μg
RNA samples using the SuperScript II reverse transcription (Invitrogen) and
the oligo(dT)15 primers (Promega) as recommended by the suppliers. Genespecific primers were purchased from Proligo (Sigma-Aldrich): HBD1,
5⬘-CAGGTGGTAACTTTCTCACAGG-3⬘ and 5⬘-AATAGAGACATTGCCCTCCACT-3⬘; HBD2, 5⬘-GCCATGAGGGTCTTGTATCTC-3⬘
and 5⬘-TTAAGGCAGGTAACAGGATCG-3⬘; HBD3, 5⬘-GTGTGTTCTGCATGGTGAGAG-3⬘ and 5⬘-TATAAAGGTTCCAGCCACAGC-3⬘;
LL37, 5⬘-CGGAAATCTAAAGAGAAGATTGG-3⬘ and 5⬘-TAGGGCACACACTAGGACTCTG-3⬘; CCL20, 5⬘-GACATAGCCCAAGAACAGAAAG-3⬘ and 5⬘-TAATTGGACAAGTCCAGTGAGG-3⬘; CCR6,
5⬘-CAGTCATCATCTCCAGCTCAAC-3⬘ and 5⬘-CTCCGAGACAGTCTGGTACTTG-3⬘. qRT-PCRs were carried out in a 20-μl volume
containing 8 μl of cDNA (diluted at 1/100), specific primers (0.2 μM each),
and 10 μl of Power SYBR Green mix (Applied Biosystems). Reactions were
run on an ABI 7900HT instrument (Applied Biosystems) with conditions of
the recommended universal thermal cycling parameters. Each reaction was
run in duplicate. Relative quantification of gene expression was performed
using the comparative Ct method. Results were normalized using the
human ␤-2-microglobulin (B2M) housekeeping gene.
Immunohistological experiments. Cryostat sections (7 μm) were prepared from human intestinal xenografts conserved in OCT. Sections were
rehydrated, blocked for 30 min in PBS with 1% BSA, and immunostained
with the following antibodies: polyclonal antibody to S. flexneri 5a LPS, polyclonal antibody to human hBD-1 (FL-68; Santa Cruz Biotechnology), polyclonal antibody to human hBD-3 (FL-67; Santa Cruz Biotechnology),
polyclonal antibody to human CCL20 (AF360; R&D Systems), and monoclonal biotinylated antibody to mouse CD11c (HL3; BD Biosciences). Slides
were washed twice in PBS before addition of the appropriate peroxidaseconjugated secondary antibody. Detection was accomplished by addition of
the liquid DAB Substrate-Chromogen System (Dako).
Antimicrobial assays. Antimicrobial activities of the synthetic human
␤-defensins hBD-1, hBD-2, hBD-3 (PeptaNova), cathelicidin LL37 (Phoenix
Pharmaceuticals), and the recombinant chemokine CCL20 (PeproTech) were
tested on the different S. flexneri strains, as previously described (29). In brief,
fresh dilutions of overnight S. flexneri cultures were subcultured for 2 h, bacteria were spun gently, resuspended in DME medium (Invitrogen) containing
5 μg/ml (CCL20) or 50 μg/ml (hBD1-3 and LL37) of the relevant peptide,
and incubated for 2 h at 37°C with intermittent shaking, in a 100-μl final volume. Because the activity of most antimicrobial factors is antagonized by high
salt concentrations, DME medium was diluted to 1:2 for these experiments
(4). Bacteria were incubated for 10 min at room temperature with 10 μg/ml
bis-(1,3-dibutylbarbituric acid)-trimethine oxonol fluorescent molecule
(DiBAC4; Invitrogen), which crosses depolarized bacterial membrane only,
before acquisition. Analysis of DiBAC4-fluorescent bacteria was performed
with a FACSCalibur apparatus (BD Biosciences) using the CellQuest Pro
software. The mean fluorescence is presented in arbitrary fluorescent units.
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Bacterial strains and culture conditions. S. flexneri serotype 5a strains
were isolated on Congo red agar plates. The invasive wild-type strain M90T
(46) and its isogenic derivatives, the invasive mxiE mutant (47) (impaired for
the MxiE transcriptional activator regulating expression of several virulence
plasmid-encoded effectors), the noninvasive mxiD mutant (48) (impaired for
the MxiD protein, a component of the TTSS required for its functionality),
and the noninvasive plasmid-cured BS176 strain (46) were used. For infection experiments, strains were cultured overnight in BTCS medium (Difco)
at 37°C with shaking. For human intestinal xenograft infections, overnight
cultures were directly used. For polarized and differentiated monolayer cell
infections, after fresh dilutions, subcultures were performed for 2 h to reach
the exponential phase, spun gently, and used after resuspension of bacteria in
DME tissue culture medium (Invitrogen).

analyzed with the S-Plus ArrayAnalyser software (Insightfull Corporation).
Preprocessing by Robust Multichip Average (RMA) was applied to process
individual probe values (perfect match) and to generate summary values for
each probe set (transcript) (52). As two replicates were done, statistical analyses were performed using the Local Pool Error test, an algorithm dedicated
to small number of replicate arrays (53). The P values were adjusted using
the Bonferroni algorithm. The dChip software was used for hierarchical
clustering with Euclidean distance and average as a linkage method (54).
Before clustering, expression values for one gene across all samples were standardized to produce a mean of zero. Increased or decreased values were then
ranged compared with that mean. Microarray data have been deposited in
National Center for Biotechnology Information Gene Expression Omnibus
(www.ncbi.nlm.nih.gov/projects/geo) and are accessible through GEO
Series accession no. GSE8636.
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Bacterial counts in infected xenograft tissues. The progression of
S. flexneri toward intestinal crypts of infected xenograft tissues was evaluated by
determining and comparing the amount of bacteria from the top of the villi to
the crypts of the mucosa. In brief, sections from xenograft tissues infected by the
wild-type S. flexneri strain M90T, and the mxiD and mxiE mutants, were
immunostained with a polyclonal antibody to S. flexneri 5a LPS, and used to
count the bacteria localized at the top of the villi (upper third), in the luminal
intervilli spaces (intermediate third), and in the crypts (lower third) of the mucosal tissues. We systematically analyzed a representative set of 10 villi per section, and 3 sections were read for 4 independent infected xenograft tissues. Data
are presented as a percentage of the amount of bacteria. The 100% is defined by
the amount of M90T bacteria determined at the upper third of the villi.
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